Nimotuzumab in Combined With Chemotherapy for Treatment of IVB Stage,Rrecurrent or Persistent Cervical Carcinoma
Clinical trial NCT06781073 · COMPLETED
Trial details
- NCT number
- NCT06781073
- Sponsor
- Biotech Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-06
- Primary completion
- 2024-11-25
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.